JeffreyMArbeitMD

Physician

Dr. Arbeit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
660 South Euclid
Saint Louis, MO 63110
Phone+1 314-362-3222

Fax+1 314-362-3246

PubMed

11 citations
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer.
Sreeja Sreekumar, Dong Zhou, Cedric Mpoy, Elsa Schenk, Jalen Scott
International Journal of Molecular Sciences. 2023-02-04
27 citations
Development of an adenovirus vector vaccine platform for targeting dendritic cells
Piyush Kumar Sharma, Igor P. Dmitriev, Elena A. Kashentseva, Geert Raes, Lijin Li
Cancer Gene Therapy. 2018-02-01
58 citations
Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer
Nicole M. White, Shuang G. Zhao, Jin Zhang, Emily B. Rozycki, Ha X. Dang
European Urology. 2017-02-01

GenVec Signs Option Agreement for Gene Editing and Cell Targeting Technology from Washington University in St. LouisJanuary 5th, 2017

Photoacoustic Microscopy Of Neovascularization In Renal Cancer Growth And TherapyNational Cancer Institute2011–2012
Small Animal Research CoreNational Cancer Institute2008–2009
Mammalian Target Of Rapamycin In Prostate CarcinogenesisNational Cancer Institute2003–2007
Hypoxia-Inducible Factor1a In Multistage CarcinogenesisNational Cancer Institute2003–2006
Hypoxia-Inducible Factor1a In Multistage CarcinogenesisNational Cancer Institute2002–2003
Core--Transgenic/Targeted MutagenesisNational Cancer Institute1999–2001
Estrogen, HPV, And Cervix Cancer In Transgenic MiceNational Cancer Institute1997–2001